# Spliceosome-inhibitor payloads

Source: https://onco.cc/terms/spliceosome-inhibitor-payloads/  
OnCo record `spliceosome-inhibitor-payloads` (Term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

These payloads disrupt the editing of gene messages before the cell uses them. Antibody-linked versions have shown activity in laboratory cancer models.

## Summary

Thailanstatin and related spliceostatin-class agents inhibit pre-mRNA splicing. Primary studies demonstrated altered splicing and antigen-dependent killing with thailanstatin antibody conjugates, including activity in a gastric cancer xenograft model. Conjugation method and drug loading affected activity. This is distinct from stopping transcription and from degrading a translation protein. Laboratory activity in resistant cell lines does not establish clinical benefit after another antibody-drug conjugate.

## Fields

- Kind: Term
- Last checked: 2026-11-08
- Also known as: RNA splicing inhibitor payloads; thailanstatin; thialanstatin; spliceostatin payloads

## Sources

- Puthenveetil et al., splicing inhibitors as conjugate payloads (2016): https://doi.org/10.1021/acs.bioconjchem.6b00291
- Site-specific thailanstatin conjugates (2017): https://doi.org/10.1371/journal.pone.0178452

## Connected records

- technologies: [Antibody-drug conjugate (ADC)](https://onco.cc/technologies/adc/)
- targets: [SF3B1](https://onco.cc/targets/sf3b1/)
- terms: [Next-generation antibody-conjugate payloads](https://onco.cc/terms/next-generation-adc-payloads/), [Payload (ADC)](https://onco.cc/terms/payload/), [Transcription-inhibitor payloads](https://onco.cc/terms/transcription-inhibitor-payloads/)

---
JSON: https://onco.cc/api/v1/entities/spliceosome-inhibitor-payloads.json